Skip to main content

Displaying 2629 - 2640 of 4658

All Star Charts Premium

The Short Report

March 24, 2022

From the desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as a market of stocks.

Regardless of the environment, there are always stocks showing leadership and trending higher. We may have to look harder to identify them depending on current market conditions… but there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club. We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week, via multiple reports. Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

We'll publish this column...

[Premium] Trade Of The Week

March 22, 2022

The market is in a recovery mode and certain stocks are outperforming others. As always, those are the names we're interested in!

Let's check out a long idea from the Paper segment.

All Star Charts Premium

[Premium] Mid-Month Conference Call Video Recording March 2022

March 21, 2022

This is the video recording of the March 2022 Mid-month Conference Call.

  • The Inflation Trade Persists - In Bonds & Commodities
  • Bearish Sentiment in Stocks - Setting Up For Further Squeeze
  • Stocks for Rising Rates Showing The Most Strength
  • Metals & Mining Stocks Still Showing Leadership
  • A lot of Bullish Retests In Global Markets Ex-U.S.
  • My Favorite Gold Stocks To Own Right Now
  • Which Growth Stocks to Bottom Fish Down Here
  • Why Aussie/Yen is so important to watch right now
  • Bitcoin AVWAP at 46K
All Star Charts Premium

Follow the Flow (03-21-2022)

March 21, 2022

From the desk of Steve Strazza @sstrazza

This is one of our favorite bottom-up scans: Follow the Flow

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish… but NOT both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

What remains is a list of stocks that large financial institutions are putting big money behind… and they’re doing so for one reason only: because they think the...

All Star Charts Premium

Under the Hood (03-21-2022)

March 21, 2022

From the desk of Steve Strazza @Sstrazza.

Welcome back to our latest Under the Hood column, where we'll cover all the action for the week ended March 18, 2022. This report is published bi-weekly and rotated with our Minor Leaguers column.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.

Watch this video for a behind-the-scenes look at our process.

Whether we’re measuring increasing interest based on...

Altimeter Capital Buys Large Stake in Confluent

March 21, 2022

The highlight of today’s list is the Altimeter Capital Form 4, which revealed a $7 million purchase in the mid-cap software stock Confluent $CFLT.

Altimeter now owns 5,131,700 shares of CFLT.

There was also a significant Form 4 filing by Sequoia Capital’s Roelof Botha, detailing a purchase in the diagnostics and research company Natera $NTRA.

Botha purchased roughly $5 million of NTRA stock, bringing his total share count to over 1.3 million.